184 related articles for article (PubMed ID: 32348827)
1. Comparison of staged excision and Mohs micrographic surgery with and without MART-1 immunostains for surgical treatment of melanoma of the head, neck, and special sites: A retrospective cohort study.
Wilson JG; German R; Hamann CR; Vidal NY; LeBoeuf M
J Am Acad Dermatol; 2021 Jan; 84(1):192-194. PubMed ID: 32348827
[No Abstract] [Full Text] [Related]
2. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
Shin TM; Nugent S; Aizman L; Weiner DM; O'Malley V; Sobanko JF; Etzkorn JR; Chu EY; Elenitsas R; Giordano CN; Higgins Ii HW; Miller CJ
J Am Acad Dermatol; 2021 Jan; 84(1):196-198. PubMed ID: 32339704
[No Abstract] [Full Text] [Related]
3. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
5. Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
Siscos SM; Neill BC; Seger EW; Rajpara A; Hocker TLH
J Am Acad Dermatol; 2021 Mar; 84(3):833-835. PubMed ID: 33022309
[No Abstract] [Full Text] [Related]
6. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
7. Syringotropic Melanoma Identified During Mohs Micrographic Surgery.
Donaldson MR; Morrell TJ; Weber LA
Dermatol Surg; 2021 Jun; 47(6):836-837. PubMed ID: 33165054
[No Abstract] [Full Text] [Related]
8. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
9. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
11. Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery.
Tate JA; Matsumoto A; Greif C; Lim J; Nijhawan RI; Srivastava D
J Am Acad Dermatol; 2024 Jun; 90(6):1226-1231. PubMed ID: 38253130
[TBL] [Abstract][Full Text] [Related]
12. The accuracy of detecting melanoma on frozen section melanoma antigen recognized by T cells 1 (MART-1) stains and on permanent sections of previously frozen tissue: A prospective cohort study.
Bhatt MD; Perz AM; Moioli E; Sobanko JF; Shin TM; Etzkorn JR; Elenitsas R; Chu EY; Higgins HW; Giordano CN; McMurray S; Krausz A; Aizman L; Lukowiak TM; Miller CJ
J Am Acad Dermatol; 2021 Jun; 84(6):1764-1766. PubMed ID: 33453343
[No Abstract] [Full Text] [Related]
13. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
14. Melanoma Treated With Mohs Micrographic Surgery Using a Novel-Modified 15-Minute MART-1 Immunostain: Discussion of Technique and Experience.
Cheraghi N; Demer A; Meister A; Lee P
Dermatol Surg; 2021 Apr; 47(4):549-551. PubMed ID: 32483096
[No Abstract] [Full Text] [Related]
15. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
17. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.
Foxton GC; Elliott TG; Litterick KA
Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208
[TBL] [Abstract][Full Text] [Related]
18. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
19. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
Hanson J; Demer A; Liszewski W; Foman N; Maher I
J Am Acad Dermatol; 2020 Jan; 82(1):149-155. PubMed ID: 31473297
[TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic excision of melanoma using immunostains.
Zalla MJ; Lim KK; Dicaudo DJ; Gagnot MM
Dermatol Surg; 2000 Aug; 26(8):771-84. PubMed ID: 10940065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
